Jane Street Group, LLC Red Hill Biopharma Ltd. Call Options Transaction History

Jane Street Group, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	SELL	$2.31 - $5.85 $189,651 - $480,284	-82,100 Reduced 66.26%	41,800 $108,000
Q3 2021 Nov 16, 2021	BUY	$4.55 - $10.36 $504,595 - $1.15 Million	110,900 Added 853.08%	123,900 $567,000
Q1 2021 May 18, 2021	BUY	$6.98 - $11.29 $90,740 - $146,770	13,000 New	13,000 $95,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.